Director at Vital Farms (VITL) receives 10,436-share RSU grant

Rhea-AI Filing Summary

Kennedy Kelly J. reported acquisition or exercise transactions in this Form 4 filing.

Vital Farms director Kelly J. Kennedy received an equity award of 10,436 restricted stock units (RSUs) for Common Stock. The award was granted at no cash cost as compensation and increases Kennedy’s direct holdings to 33,363 shares.

The RSUs will vest on the earlier of June 10, 2027 or the day before Vital Farms’ next annual stockholder meeting, as long as Kennedy remains in continuous service with the company through that date. This filing reflects a routine board-level equity grant rather than an open-market share purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kennedy Kelly J.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,436	$0.00	--

Holdings After Transaction: Common Stock — 33,363 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 10,436 shares Grant price: $0.00 per share Holdings after grant: 33,363 shares +1 more

4 metrics

RSU grant size 10,436 shares Restricted stock unit award of Common Stock to director

Grant price $0.00 per share Equity compensation, not an open-market purchase

Holdings after grant 33,363 shares Total direct Common Stock beneficially owned post-transaction

Latest vesting date June 10, 2027 RSUs vest on earlier of this date or day before next annual meeting

Key Terms

restricted stock unit ("RSU") award, continuous service, annual meeting of stockholders

3 terms

restricted stock unit ("RSU") award financial

"Represents a restricted stock unit ("RSU") award."

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer"

annual meeting of stockholders financial

"the day before the Issuer's next annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Kelly J.

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		10,436(1)	A	$0	33,363	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of (1) June 10, 2027 and (2) the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

	/s/ Francis Cullo, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vital Farms (VITL) report for Kelly J. Kennedy?

Vital Farms reported that director Kelly J. Kennedy received a grant of 10,436 restricted stock units (RSUs) of Common Stock. The award was made at no cash cost as equity compensation, increasing Kennedy’s direct holdings to 33,363 shares after the transaction.

When do Kelly J. Kennedy’s new Vital Farms (VITL) RSUs vest?

The 10,436 Vital Farms RSUs granted to Kelly J. Kennedy vest on the earlier of June 10, 2027 or the day before the company’s next annual meeting of stockholders, provided Kennedy continues serving the company through the applicable vesting date.

How many Vital Farms (VITL) shares does Kelly J. Kennedy hold after this Form 4?

After the RSU grant, Kelly J. Kennedy is reported to beneficially own 33,363 shares of Vital Farms Common Stock directly. This total reflects the addition of 10,436 RSUs awarded as equity compensation in the latest transaction disclosed.

Was Kelly J. Kennedy’s Vital Farms (VITL) transaction a market purchase or sale?

The filing shows an acquisition coded as a grant or award, not a market trade. Kennedy received 10,436 RSUs at a stated price of $0.00 per share as part of director compensation, rather than buying or selling shares on the open market.

What conditions apply to Kelly J. Kennedy’s RSU award at Vital Farms (VITL)?

The RSU award is subject to continuous service with Vital Farms through vesting. The 10,436 RSUs vest on the earlier of June 10, 2027 or the day before the next annual stockholder meeting, assuming Kennedy remains a service provider to the company.